Rationale and design of a phase III trial of adjuvant sequential epirubicin/ cyclophosphamide and taxane versus concurrent epirubicin/taxane in operable node-positive breast cancer.

E. A. Perez

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'Rationale and design of a phase III trial of adjuvant sequential epirubicin/ cyclophosphamide and taxane versus concurrent epirubicin/taxane in operable node-positive breast cancer.'. Together they form a unique fingerprint.

Medicine & Life Sciences